The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has killed millions from coronavirus disease 19 (COVID-19). Retrospective studies indicate that individuals infected with SARS-CoV-2 ...
SARS-CoV-2 has diversified rapidly since its emergence, spawning multiple lineages defined by distinct mutations in the spike glycoprotein and elsewhere in the genome. Characterisation of these ...
New Instrument Counts and Sizes Viruses and Their Aggregates in Liquid Suspension There are two main categories of viral vaccines—live (attenuated) and killed (inactivated) vaccines. A live attenuated ...
A new method that can rapidly determine whether a virus is infectious or non-infectious could revolutionise the response to future pandemics. Dr Samuel Jones from Birmingham’s School of Chemistry led ...
In a recent study posted to the bioRxiv* preprint server, researchers performed an epidemic dynamic analysis to assess the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant ...
The use of viruses and viral vectors in gene therapy, cell therapy, vaccines and basic research requires precise infectious titer assessments, often hindered by tedious and lengthy infectivity assays.
Overview of Lab Data Capture (LDC) Workflow Implementation. LDC supports file ingestion from multiple data sources including analytical instruments, data historians and ELN/LIMS. After ingestion, ...
CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--LumaCyte, a leader in advanced label-free single-cell analytics through its novel Laser Force Cytology™ (LFC™) platform, announces today the addition of Jim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results